Aminoguanidine (AG) is a hydrazine derivative that inhibits inducible NO synthase (iNOS) and thus reduces cGMP production.[23] Intracerebroventricular infusion of AG can block depression-like behaviors resulting from chronic unpredictable stress paradigms.[24]. Here, NOS2 is linked to depressive symptom measurement.